SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?


To: idahoranch1 who wrote (8337)11/25/2009 7:08:30 PM
From: stockdoc771 Recommendation  Respond to of 63288
 
I think someone got lonely and frustrated on YMB so came looking for attention.



To: idahoranch1 who wrote (8337)11/25/2009 7:10:45 PM
From: erickerickson  Read Replies (1) | Respond to of 63288
 
And I finally looked at the various options and figured out that even a cheap bastard like me can afford $20/year for the cause....

In case anyone else looks, go ahead and check it out, the overall membership level page confused me. Go here:
siliconinvestor.com
and, near the bottom of the page click on the "Click here to view your available subscription options" link. That presents a much clearer list of what *your* account allows.

FWIW
Erick



To: idahoranch1 who wrote (8337)11/25/2009 8:19:07 PM
From: targetedmoab  Read Replies (2) | Respond to of 63288
 
Idaho
I was curious on something. Are you the patients physician? I guess I am a little bewildered in that if you were, they are on a trial and you are giving away inside info...or are you an IMMU insider? If you are not their physician and another MD OR just a average investor, isnt it a little unethical to call a patient on a trial and then talk about results on an investment website? I mean if I were a patient I would be a little po'd if someone that is an investor in the company I am on a drug trial were to call me to ask how it is going.
I work in the cancer pharma industry and I know all the confidentiality that is involved with studies on pre commercialized drugs and there just seems to something seriously wrong about your last post.